Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Anti-Inflammatory Therapeutics Market from 2024 to 2025?

In recent times, there has been consistent growth in the market size of anti-inflammatory therapeutics. It is projected to increase from $114.71 billion in 2024 to $118.44 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.3%. Factors that have contributed to the growth during the historic period include the rise of chronic diseases, an aging population, heightened awareness, and government initiatives.

What Is the Projected Market Size of the Anti-Inflammatory Therapeutics Market?

Projected to see substantial growth in the coming years, the anti-inflammatory therapeutics market is estimated to reach $144.05 billion in 2029, growing at a compounded annual growth rate of 5.0%. This anticipated growth within the forecast period is largely due to innovative treatments, heightened healthcare spending, emphasis on rare diseases, and the development of biologics and biosimilars. Key trends expected to influence the forecast period include progresses in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in pharmaceutical discovery, and an extended range of indications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Who are the Major Competitors in the Anti-Inflammatory Therapeutics Market Outlook?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

What Is Fueling Growth in the Anti-Inflammatory Therapeutics Market?

The growth of the anti-inflammatory therapeutics market is likely to be fuelled by the rising incidence of inflammatory bowel disease. Gastrointestinal inflammation, a characteristic of this chronic ailment, is effectively treated with anti-inflammatory therapeutics. They aid in managing the disease’s symptoms, lessening inflammation, and mitigating the chance of surgery. According to the Oxford University Press in July 2023, inflammatory bowel disease has a prevalence rate of 721 per 100,000 individuals and incidences are at a rate of 10.9 per 100,000 person-years. This escalating occurrence of inflammatory bowel disease propels the growth of the anti-inflammatory therapeutics market. With an anticipated surge in autoimmune disorder incidences, there is an expected robust growth in the anti-inflammatory therapeutics market. Autoimmune disorders, a medical condition that mistakenly activates the immune system to launch an attack on the body’s healthy cells, have been on the rise. Anti-inflammatory therapeutics are critical in the management of these disorders, where they work to curtail inflammation, control the exaggerated reaction of the immune system, and alleviate symptoms associated with these disorders. As projected by the Guardian Media Group in January 2022, autoimmune disorders will affect 4 million individuals in the UK and globally the rates are are expected to increase annually by 3% to 9%. Furthermore, Oxford University reported in May 2023, that 10% of the global population is affected by autoimmune disorders. This surge in autoimmune disorders bolsters the growth of the anti-inflammatory therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Which Anti-Inflammatory Therapeutics Market Segments Are Growing the Fastest?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Which Industry Trends Are Shaping the Future of the Anti-Inflammatory Therapeutics Market?

Leading businesses in the anti-inflammatory therapeutics market are debuting groundbreaking drugs to fortify their market presence. For example, in February 2023, US-based biotech firm Regeneron Pharmaceuticals Inc., together with Sanofi, a pharmaceutical and healthcare firm from France, unveiled Kevzara (sarilumab). This is the first and sole anti-inflammatory biologic suggested for adult patients suffering from polymyalgia rheumatic (PMR), an inflammatory rheumatic disorder, which fails to respond adequately to corticosteroids or whose tolerance to corticosteroid tapering is low.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Countries Are Leading the Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

This Report Delivers Insight On:

1. How big is the anti-inflammatory therapeutics market, and how is it changing globally?

2. Who are the major companies in the anti-inflammatory therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the anti-inflammatory therapeutics market right now?

4. Which products or customer segments are growing the most in the anti-inflammatory therapeutics market?

5. What factors are helping or slowing down the growth of the anti-inflammatory therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model